Top Cities for Xeroderma Pigmentosum Clinical Trials
Xeroderma Pigmentosum clinical trials are recruiting across 8 cities. Here are the cities with the most active studies:
About Xeroderma Pigmentosum
Xeroderma pigmentosum is a rare genetic disorder characterized by extreme sensitivity to ultraviolet light, leading to very high risk of skin cancer and eye damage. It is caused by defects in DNA repair mechanisms. Management requires strict UV protection and vigilant cancer surveillance.
Clinical trials are advancing new treatments for xeroderma pigmentosum. Currently, 1 studies are recruiting a combined 2,076 participants across the United States. Research is being conducted by 1 organizations including Guerbet.
2026 Xeroderma Pigmentosum Research Landscape
As of March 2026, the xeroderma pigmentosum clinical trial landscape includes 1 actively recruiting studies across 8 cities in the United States. These studies are collectively seeking 2,076 participants, with an average enrollment target of 2,076 per study.
Research is being led by 1 organization, including Guerbet.
Geographically, xeroderma pigmentosum trials are most concentrated in Boston, Massachusetts (3 trials); Scottsdale, Arizona (1 trial); New Haven, Connecticut (1 trial); Chicago, Illinois (1 trial); Peoria, Illinois (1 trial) and 3 other cities.
Featured Xeroderma Pigmentosum Studies
Highlighted recruiting studies for xeroderma pigmentosum, selected by enrollment size and research scope.
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
This study is a postmarketing requirement jointly carried out by four NDA holders (Bayer AG, Bracco, GE Healthcare and Guerbet) and the CRO IQVIA. The study aims to create detailed images of the organs and tissue of the human body during x-ray, CT-scan or MRI investigations, doctors are using contrast media (a kind of dye) which can be given to patients by injection into a blood vessel or by mout...
Frequently Asked Questions About Xeroderma Pigmentosum Clinical Trials
Are there xeroderma pigmentosum clinical trials near me?
Yes, there are 1 xeroderma pigmentosum clinical trials currently recruiting across 8+ cities in the United States, including Boston, Massachusetts; Scottsdale, Arizona; New Haven, Connecticut. Browse the studies above to find one at a location convenient for you.
How do I join a xeroderma pigmentosum clinical trial?
To join a xeroderma pigmentosum clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are xeroderma pigmentosum clinical trials free?
Yes, participation in xeroderma pigmentosum clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of xeroderma pigmentosum treatments are being studied?
Current xeroderma pigmentosum clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 1 research organizations.
Is it safe to participate in xeroderma pigmentosum clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov